Sumitomo Pharma, Novo Nordisk Pharma sign co-promotion agreement for Wegovy Subcutaneous Injection in Japan (¥1714.0000, 0)
StreetAccount Summary - Trading higher/lower: Japan mid-day
StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (131 total)
StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (41 total)
Sumitomo Pharma reports interim analysis results of Phase 1 Clinical Study) of fH1/DSP-0546LP presented (¥1729.0000, +18)
White House says the latest pharmaceutical tariffs do not apply to countries with negotiated trade deals -- wires
Trump says pharmaceutical products imported into US will be hit with 100% tariff starting 1-Oct - Truth Social post
Powered by FactSet Research Systems Inc.